Citation Impact

Citing Papers

Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Human Fibrinogen
1988
An elastase-dependent pathway of plasminogen activation
1989
An initiation site for meiotic gene conversion in the yeast Saccharomyces cerevisiae
1989 StandoutNatureNobel
Moojenactivase, a novel pro-coagulant PIIId metalloprotease isolated from Bothrops moojeni snake venom, activates coagulation factors II and X and induces tissue factor up-regulation in leukocytes
2015
Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling.
1998 StandoutNobel
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis
1990
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Intragonadal Regulation of Follicular Maturation
1989
Tissue Plasminogen Activator Contributes to the Late Phase of LTP and to Synaptic Growth in the Hippocampal Mossy Fiber Pathway
1998 StandoutNobel
Cell biology of tissue factor, the principal initiator of blood coagulation
1996
Physical Fitness as a Predictor of Mortality among Healthy, Middle-Aged Norwegian Men
1993
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Circadian Variation of Fibrinolytic Activity in Blood
1991
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Physiological consequences of loss of plasminogen activator gene function in mice
1994 Nature
Tissue‐type plasminogen activator and C‐reactive protein in acute coronary heart disease. A nested case–control study
2000
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Disseminated Intravascular Coagulation
1999 Standout
Activation of Hepatocyte Growth Factor in the Injured Tissues Is Mediated by Hepatocyte Growth Factor Activator
1996
Impaired arterial neointima formation in mice with disruption of the plasminogen gene.
1997
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Biochemical and biological aspects of the plasminogen activation system
1990
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Kinetic studies of the urokinase-catalysed conversion of NH2-terminal glutamic acid plasminogen to plasmin
1977
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Plasminogen activator inhibitors
1987
Studies on the mechanism of the antifibrinolytic action of tranexamic acid
1981
Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells.
1982 StandoutNobel
LEUKOTACTIC FACTORS ELABORATED BY VIRUS-INFECTED TISSUES
1972 StandoutNobel
Plasmin-catalysed cleavage of single chain tissue-type plasminogen activator in fibrin clots
1989
A recombinant pro-urokinase derived mutant missing the growth factor-like domain does not bind to its receptor
1990
Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein
1978
C3 LEUKOTACTIC FACTORS PRODUCED BY A TISSUE PROTEASE
1969
STUDIES ON THE FREE AMINO ACIDS AND RELATED COMPOUNDS IN THE TISSUES OF THE CAT
1954 StandoutNobel
Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
1990 Standout
TYROSINE-O-SULFATE AS A CONSTITUENT OF NORMAL HUMAN URINE
1955 StandoutNobel
The mesothelium: Its fibrinolytic properties
1982
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: Host cell activation of serum plasminogen
1973
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
The level of extrinsic plasminogen activator (t-PA) during clotting as a determinant of the rate of fibrinolysis; inefficiency of activators added afterwards
1984
Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator
1984
Complex Formation between Metallic Cations and Proteins, Peptides, and Amino Acids
1956
Automatic Recording Apparatus for Use in Chromatography of Amino Acids
1958 StandoutNobel
Characterization of pro-opiocortin-converting activity in purified secretory granules from rat pituitary neurointermediate lobe.
1982
DEFIBRINATION SYNDROME IN PREGNANCY VALUE OF VARIOUS DIAGNOSTIC TESTS
1958
Generation and reproductive phenotypes of mice lacking estrogen receptor β
1998 StandoutNobel
Plasminogen: Purification from Human Plasma by Affinity Chromatography
1970 StandoutScience
A note on the free amino acid content of rat brain
1954
l-CYSTATHIONINE IN HUMAN BRAIN
1958 StandoutNobel
IMPAIRMENT OF PLATELET FUNCTION BY GROWTH-HORMONE RELEASE- INHIBITING HORMONE
1975 StandoutNobel
Organ Distribution of Fibrin in Disseminated Intravascular Coagulation
1969
PROPERTIES OF GUINEA PIG 7S ANTIBODIES
1963 StandoutNobel
Reduced human peritoneal plasminogen activating activity: Possible mechanism of adhesion formation
1989
THE FREE AMINO ACIDS OF HUMAN BLOOD PLASMA
1954 StandoutNobel
Fibrinogen level as a predictor of mortality in survivors of myocardial infarction
1991
N-ACETYL-l-ASPARTIC ACID IN BRAIN
1956 StandoutNobel
METABOLISM OF FREE AMINO ACIDS IN FASTED AND ZEIN-FED RATS
1954
Prostacyclin is a circulating hormone
1978 StandoutNatureNobel
Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
1986
A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions
1976
Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator.
1982
Biomaterial-Centered Infection: Microbial Adhesion Versus Tissue Integration
1987 StandoutScience
Identification of the Cystic Fibrosis Gene: Genetic Analysis
1989 StandoutScience
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Binding of plasminogen to extracellular matrix.
1986
Excessive consumption of blood coagulation components as cause of hemorrhagic diathesis
1965
Localization of Individual Lysine‐Binding Regions in Human Plasminogen and Investigations on Their Complex‐Forming Properties
1980
Liver Regeneration
1997 StandoutScience
Characterization of an Extremely Large, Ligand-Induced Conformational Change in Plasminogen
1990 StandoutScienceNobel
Radioimmunoassay of ACTH in plasma
1968 StandoutNobel
Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex.
1986
SYNTHESIS, INTRACELLULAR TRANSPORT AND DISCHARGE OF EXPORTABLE PROTEINS IN THE PANCREATIC ACINAR CELL AND OTHER CELLS
1978
Circadian Variation in the Frequency of Onset of Acute Myocardial Infarction
1985
Role of Fibronectin in the Prevention of Adherence of Pseudomonas aeruginosa to Buccal Cells
1981
PROCEDURES FOR THE CHROMATOGRAPHIC DETERMINATION OF AMINO ACIDS ON FOUR PER CENT CROSS-LINKED SULFONATED POLYSTYRENE RESINS
1954 StandoutNobel
Macrophage fibrinolytic activity: Identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor
1982
Tissue plasminogen activator and urokinase mediate the binding of Glu-plasminogen to plasma fibrin I. Evidence for new binding sites in plasmin-degraded fibrin I.
1985
The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
1983
Molecular mechanism of physiological fibrinolysis
1978 Nature
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption
1982
Physical Activity and the Incidence of Coronary Heart Disease
1987
Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis
1984
One-step gene replacement in yeast by cotransformation
1985
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
1982
Relative proteolysis of the fibrinogen Bβ chain by thrombin and plasmin as a determinant of thrombosis
1981 Nature
STUDIES IN THE TREATMENT OF THE PULMONARY SYNDROME OF THE NEWBORN
1962 StandoutNobel
Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-α-factor
1984 StandoutNobel
Tumors: Wounds That Do Not Heal
1986 Standout
Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.
1989
Serosal hypofibrinolysis
1973
Metal Content of α-Amylases of Various Origins
1959 StandoutNobel
Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators.
1982
Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.
1988
Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium
1977 StandoutNobel
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.
1983
A functionally active heavy chain derived from human high molecular weight urokinase.
1983
ε-Aminocaproic Acid: an Inhibitor of Plasminogen Activation
1959
Lys49 myotoxin from the Brazilian lancehead pit viper elicits pain through regulated ATP release
2017 StandoutNobel
Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.
1985
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.
1990 StandoutNobel
Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli
1985
A Deficiency of Pulmonary Fibrinolysis in Hyaline-Membrane Disease
1960
THE DESTRUCTION OF GLUCAGON, ADRENOCORTICOTROPIN AND SOMATOTROPIN BY HUMAN BLOOD PLASMA*
1959
The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis
1967
Anchorage independent growth and plasminogen activator production by bovine endothelial cells.
1980

Works of Tage Astrup being referenced

Fibrinolytic activity of reparative connective tissue
1964
Biphasic Inhibition of Urokinase-Induced Fibrinolysis by isin-Aminocaproic Acid; Distinction from Tissue Plasminogen Activator
1969
Localization of Fibrinolytic Activity in Myocardial Infarcts in Rats
1964
Impairment of growth and pancreatic hypertrophy in rats fed trypsin inhibitor from raw peanuts
1968
Blood Fibrinolytic Activity in Man
1970
Release of Plasminogen Activator from Viable Leukocytes of Man, Baboon, Dog and Rabbit
1972
A Study of the Fibrin Plate Assay of Fibrinolytic Agents
1983
Estimation of the Plasminogen Activator and the Trypsin Inhibitor in Animal and Human Tissues
1957
Blood coagulation and fibrinolysis in tissue culture and tissue repair
1968
Differences in the Binding to Fibrin of Urokinase and Tissue Plasminogen Activator
1972
Estimation of proteolytic enzymes by means of their fibrinolytic activity
1952
ROLE OF BLOOD COAGULATION AND FIBRINOLYSIS IN THE PATHOGENESIS OF ARTERIOSCLEROSIS.
1964
Fibrinolytic activity in serosal and synovial membranes. Rats, guinea pigs, and rabbits.
1969
Fractional Precipitation of Serum Proteins by Heavy Metal Ions.
1954
An Activator of Plasminogen in Normal Urine.
1952
Quaternary Detergents and the Activity of Trypsin and Plasmin
1951 Nature
Thromboplastin and plasminogen activator in tissues of the rabbit
1970
Tissue activators of plasminogen.
1990
The fibrin plate method for estimating fibrinolytic activity
1952
Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
1974
Thromboplastic and Fibrinolytic Activity of the Human Aorta
1959
Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique.
1967
A Desalting Apparatus for Amino Acids.
1951
Fibrinolytic Activity in Human Atherosclerotic Coronary Arteries
1967
Isolation of a Soluble Fibrinolytic Activator from Animal Tissue
1952 Nature
Fibrinolytic Activity of Cirrhotic Liver
1960 Nature
Thromboplastic and Fibrinolytic Activity of the Arteriosclerotic Human Aorta
1962 Nature
Inhibition by hydrocortison of plasminogen activator production in rat tongue organ cultures.
1974
Classification of Proteolytic Enzymes by Means of their Inhibitors
1952 Nature
Analytical Review: Fibrinolysis in the Organism
1956
Impairment of the Diurnal Fibrinolytic Response in Man
1973
THE BIOLOGICAL SIGNIFICANCE OF FIBRINOLYSIS
1956
Selective Inhibition in Human Pregnancy Blood of Urokinase Induced Eibrinolysis
1963
Assay and Content of Tissue Thromboplastin in Different Organs*
1965
The Plasminogen Activator in Animal Tissue
1956
Isolation and purification of a tissue plasminogen activator and its comparison with urokinase
1969
Fibrinogenolysis and Fibrinolysis with Tissue Plasminogen Activator, Urokinase, Streptokinase-Activated Human Globulin, and Plasmin
1971
Substrate Composition and the Effect of ε-Aminocaproic Acid on Tissue Plasminogen Activator and Urokinase-induced Fibrinolysis
1974
A Fibrinolytic System in Human iMilk.
1953
Free Amino Acids in Mammalian Tissue
1951
Fibrinolysis
1952
Rankless by CCL
2026